| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.004 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.005 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.005 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
| mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.007 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.008 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.008 |
| mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.008 |